AI-generated summary
Boehringer Ingelheim has previously participated in a number of key clinical studies in China, and the completion of this R&D center marks a new stage of its R&D layout in China.
China News Service, Shanghai, October 12 (Reporters: Xu Jing and Tang Yanjun) Boehringer Ingelheim, a world-renowned biopharmaceutical company, officially opened its new China R&D center in Zhangjiang, Shanghai on the 12th, marking a new stage of its R&D layout in China.
It is reported that the Chinese R&D center integrates four core capabilities: early clinical development, external innovation cooperation, drug development, clinical pharmacology and non-clinical safety science. The newly established early stage medicine team will drive the development of innovative projects through disease mechanism research, biomarker development, and clinical proof-of-concept studies. In the future, the company will actively promote China's participation in all pre-proof-of-concept clinical development projects.
The external innovation team will further deepen cooperation with China's rapidly developing innovation ecosystem, actively explore, evaluate and promote cooperation opportunities, support more authorized introduction and cooperation projects, and contribute innovative results to the company's global R&D pipeline. The drug development and clinical pharmacology and non-clinical safety science teams will also continue to provide support for early development and scientific decision-making.
Paola Casarosa, member of the Executive Board of Boehringer Ingelheim and head of the Innovation Division, said that the completion of the China R&D Center reflects the company's confidence in China's innovation ecosystem and scientific research talents, highlighting the strategic position of the Chinese team in the group's global R&D system. She looks forward to the Chinese team helping more breakthrough therapies benefit patients around the world.
Currently, Boehringer Ingelheim's China team participates in all of the company's key clinical studies and more than 70% of early clinical research projects. It undertakes important work in drug development, clinical pharmacology and other fields, and promotes the global debut of multiple innovative drugs in China or simultaneous global approval.
AI outlook — possibilities, not facts
Chinese teams will participate in more proof-of-concept pre-clinical development projects
Very likely · Within months

The 2026 Nobel Prize in Economic Sciences will be jointly won by American economists Robert Hall and Michael Woodford. The two won the award for establishing economic models based on micro-subject behaviors and providing a theoretical basis for global central bank decision-making.

The Royal Swedish Academy of Sciences announced that the 2026 Nobel Prize in Economic Sciences will be awarded to Robert E. Hall and Michael Woodford in recognition of their development of macroeconomic models that laid the theoretical foundation of microeconomics for the implementation of effective economic stabilization policies.
The first batch of exhibits at the 9th China International Import Expo was successfully cleared by Shanghai Customs on October 12. This batch of exhibits is the turn-milling composite machining center of the Austrian WFL company, which is the first exhibition in Asia. Shanghai Customs has opened special windows and channels to improve customs clearance efficiency and ensure the smooth holding of the CIIE.
The 19th China-EU Investment, Trade, Science and Technology Cooperation Fair will be held in Chengdu from October 21st to 23rd. Companies from more than 20 European countries will participate in the conference, focusing on exploring cooperation in new energy, biomedicine, intelligent robots and other fields, aiming to deepen China-EU economic, trade and scientific and technological exchanges.

China and the EU have finalized a trade agreement imposing quotas on Chinese hybrid car exports to Europe while reducing Chinese tariffs on European goods, aiming to ensure stable export growth.

The Taiyuan Department Store near Tainan Train Station launched the "Get off the train and celebrate the anniversary" event in conjunction with the opening of the Tainan Railway's first underground railway on October 17. Members can redeem 400 yuan vouchers with their train tickets on the same day, and hold retro costumes, food exhibitions and various anniversary full reward discounts.